Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Historical price data

Hebei Changshan Biochemical Pharmaceutical is a key manufacturer in the global heparin market, specializing in the production of heparin sodium and low molecular weight heparin (LMWH) APIs and preparations. The company leverages its integrated supply chain from raw heparin sourcing to finished drug production. As a public company listed on the Shenzhen Stock Exchange, it faces both significant market opportunities in the growing antithrombotic drug sector and challenges related to raw material supply, regulatory scrutiny, and competitive pressures.

Integrated biochemical platform for the extraction, purification, and depolymerization of heparin from porcine intestinal mucosa to produce heparin sodium and various low molecular weight heparin (LMWH) APIs and finished injectable drugs.

Competes globally with pharma giants like Pfizer and Sanofi, and domestically with other large Chinese heparin API producers like Nanjing King-Friend. Differentiation is based on scale, vertical integration, cost efficiency, and the ability to consistently meet stringent international quality standards for API export.